Clinical Trial Update: A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV) [Phase 3]

View source ↗

Summary

Phase 3 study of Rilematovir in infants, children, and neonates hospitalized with RSV-related respiratory infection was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Rilematovir (rilematovir)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Respiratory Tract Infections | Phase 3 | Status: TERMINATED | Results posted: 2023-04-10